Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Artificial intelligence in diabetes mellitus and endocrine diseases — what can we expect?

Nature Reviews Endocrinology volume 19, pages 375–376 (2023)Cite this article

Subjects

Artificial intelligence has already revolutionized various fields in medicine and research. Due to the complex and interconnected nature of the endocrine system, it is an ideal area to further exploit and maximize the potential benefits of artificial intelligence.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gardiner, L. J. et al. Interpreting machine learning models to investigate circadian regulation and facilitate exploration of clock function. Proc. Natl Acad. Sci. USA 118, e2103070118 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Nimri, R. et al. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nat. Med. 26, 1380–1384 (2020).

    Article  CAS  PubMed  Google Scholar 

  3. Liu, H. et al. Computed tomography-based machine learning differentiates adrenal pheochromocytoma from lipid-poor adenoma. Front. Endocrinol. (Lausanne) 13, 833413 (2022).

    Article  PubMed  Google Scholar 

  4. Wang, Z. et al. Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer. BMC Cancer 23, 128 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Turai, P. I. et al. Tissue miRNA combinations for the differential diagnosis of adrenocortical carcinoma and adenoma established by artificial intelligence. Cancers 14, 895 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Shi, X. et al. Cancer stemness associated with prognosis and the efficacy of immunotherapy in adrenocortical carcinoma. Front. Oncol. 11, 651622 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hathaway, Q. A. et al. Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics. Cardiovasc. Diabetol. 18, 78 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vasey, B. et al. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nat. Med. 28, 924–933 (2022).

    Article  CAS  PubMed  Google Scholar 

  9. Dimai, H. P. New horizons: artificial intelligence tools for managing osteoporosis. J. Clin. Endocrinol. Metab. 108, 775–783 (2023).

    Article  PubMed  Google Scholar 

  10. Naser, J. A. et al. Artificial intelligence-augmented electrocardiogram in determining sex: correlation with sex hormone levels. Mayo Clin. Proc. 98, 541–548 (2023).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the support of the German Federal Ministry of Education (Clusters4Future SaxoCell, 03ZU1111DA) and the German Research Foundation (DFG, project no. 314061271 and project no. 288034826).

Author information

Authors and Affiliations

  1. Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

    Ioannis T. Oikonomakos, Charlotte Steenblock & Stefan R. Bornstein

  2. School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK

    Stefan R. Bornstein

  3. Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland

    Stefan R. Bornstein

Authors
  1. Ioannis T. Oikonomakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charlotte Steenblock
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan R. Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan R. Bornstein.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oikonomakos, I.T., Steenblock, C. & Bornstein, S.R. Artificial intelligence in diabetes mellitus and endocrine diseases — what can we expect?. Nat Rev Endocrinol 19, 375–376 (2023). https://doi.org/10.1038/s41574-023-00852-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-023-00852-1

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer